Life ScienceCompany
Grünenthal has acquired 7 companies, including 5 in the last 5 years.
Grünenthal’s largest acquisition to date was in 2022, when it acquired Nebido for $563M. Grünenthal has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (72%) and medical products (29%).
Join Mergr and gain access to Grünenthal’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity7
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 2
Unlimited Searches
